Related Experiment Video
Updated: Jul 6, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Necrotizing leukoencephalopathy following CHOP chemotherapy
Anne H Blaes1, Karen S Santa-Cruz, Chung K K Lee
1University of Minnesota, Department of Medicine, Division of Hematology/Oncology/Transplantation, United States. blaes004@umn.edu
Leukemia Research
|April 2, 2008
Summary
Toxic leukoencephalopathy is a rare brain disorder. This study reports a second fatal case linked to CHOP chemotherapy for non-Hodgkin lymphoma, highlighting a critical adverse effect.
Area of Science:
- Neurology
- Oncology
- Toxicology
Background:
- Toxic leukoencephalopathy syndromes are rare neurological disorders affecting white matter.
- Etiologies include hypertension, irradiation, toxins, and chemotherapy agents.
- Leukoencephalopathy is a known, albeit rare, complication of chemotherapy.
Observation:
- A case of fatal necrotizing leukoencephalopathy is presented.
- This occurred following the administration of CHOP chemotherapy.
- This is the second reported fatal case associated with this treatment.
Findings:
- CHOP chemotherapy can lead to fatal necrotizing leukoencephalopathy.
- This rare adverse effect impacts the brain's white matter.
- The syndrome presents with neurological dysfunction.
Implications:
- Clinicians should be aware of this rare but severe complication of CHOP chemotherapy.
- Further research may elucidate mechanisms and preventative strategies.
- This finding underscores the importance of monitoring neurological function in patients receiving chemotherapy.
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...